Feb. 20 at 7:14 PM
$DRMA has two patent for a drug that has already passed clinical trials and fda acceptance of drug name… why they chose to not go fda approval route and instead chosen to get this drug patent protection cause they are in the market for a buyer this is just my opinion and I’m sticking to this some company will buy this and make billions the drug works has dual patents and fda approval
